See also this year's filing and all EDGAR filings for this company.
PDF Report 0001720893_2019_Bioxcel_Therapeutics_Inc.pdf
Logs
Graph
Absolute values for 0001720893, Bioxcel Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 43,171,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 327,000 |
| 3 | remainder_Assets | 51,000 |
| 4 | LiabilitiesCurrent | 4,660,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 5,404,000 |
| 9 | ResearchAndDevelopmentExpense | 14,558,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 692,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 43,549,000 |
| 1 | Liabilities | 4,660,000 |
| 2 | Expenses | 19,962,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 38,889,000 |
| 5 | NetIncome | -19,270,000 |
| 6 | ComprehensiveNetIncome | -19,270,000 |
| 7 | BaseVar | 34,431,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.72 |
| 9 | EconomicCapitalRatio | 3.50 |
Edgar->Model Mapping
Feature Distribution
